AXDRUG
Live / Applied — Statement of use — processing complete, to examiner (as of 15 Sept 2026)
What this means for you
Not registered yet, but its 01 Jul 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99262326
- Mark type
- Stylized text
- Filed
- 01 Jul 2025
- Published for opposition
- 23 Dec 2025
- Attorney of record
- RAVI PAUL VARMA
Goods and services
- Class 042 — Scientific and technological services: Scientific and technological services, namely, computational drug discovery, AI-based molecular pharmaceutical design, laboratory-based pharmaceutical research, and custom chemical synthesis; research and development of small molecules and biologics in the field of pharmaceutical and therapeutic discovery
Owner
- Immunocure Inc., Livingston, NJ, US
- Immunocure Inc., Livingston, NJ, US
Prosecution history
- 15 Sept 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Aug 2026 — USE AMENDMENT FILED
- 17 Aug 2026 — TEAS STATEMENT OF USE RECEIVED
- 19 Jun 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Jun 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Jun 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Dec 2025 — PUBLISHED FOR OPPOSITION
- 17 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Nov 2025 — EXAMINER'S AMENDMENT ENTERED
- 25 Nov 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 25 Nov 2025 — EXAMINERS AMENDMENT E-MAILED
- 25 Nov 2025 — EXAMINERS AMENDMENT -WRITTEN